Clinical Trial Update: Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C [NA]

View source ↗

Summary

A completed clinical trial evaluating a lifestyle intervention to reduce obesity and insulin resistance in people with chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Insulin Resistance
• Metabolic Syndrome
• Obesity

Snippet

Sponsor: University Health Network, Toronto | Conditions: Obesity, Insulin Resistance | NA | Status: COMPLETED